Prokinetic therapy with erythromycin has no significant impact on blood pressure and heart rate in critically ill patients [1]

British Journal of Clinical Pharmacology

Volumn 63, Issue 4, 2007, Pages 498-500

  Nguyen, N Q ^a,c   Mangoni, A A ^b,d   Fraser, R J ^c   Chapman, M ^a   Bryant, L ^c   Burgstad, C ^a   Holloway, R H ^a,c  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROMYCIN; MOTILIN; PLACEBO; PROKINETIC AGENT;

ADULT; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GASTROESOPHAGEAL REFLUX; HEART HEMODYNAMICS; HEART RATE; HUMAN; LETTER; MALE; PRIORITY JOURNAL; SINGLE DRUG DOSE; STATISTICAL MODEL; STOMACH DISEASE; STOMACH EMPTYING; SYSTOLIC BLOOD PRESSURE; TUBE FEEDING;

BLOOD PRESSURE; CRITICAL ILLNESS; ERYTHROMYCIN; FEMALE; GASTRIC EMPTYING; GASTROINTESTINAL AGENTS; HEART RATE; HUMANS; MALE; MIDDLE AGED;

EID: 33947237865     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2006.02772.x     Document Type: Letter

References (11)

1. De B, Chapman M, Fraser R, Finnis M, De Keulenaer B, Liberalli D, Satanek M. Enteral nutrition in the critically ill: a prospective survey in an Australian intensive care unit. Anaesth Intensive Care 2001; 29: 619-22.
2. Mutlu GM, Mutlu EA, Factor P. GI complications in patients receiving mechanical ventilation. Chest 2001; 119: 1222-41.
3. Heyland D, Cook DJ, Winder B, Van Brylowski L, deMark H, Guyatt G. Enteral nutrition in the critically ill patient: a prospective survey. Crit Care Med 1995; 23: 1055-60.
4. Stroud M, Duncan H, Nightingale J. Guidelines for enteral feeding in adult hospital patients. Gut 2003; 52 (Suppl. 7): vii1-vii12.
5. MacLaren R. Intolerance to intragastric enteral nutrition in critically ill patients: complications and management. Pharmacotherapy 2000; 20: 1486-98.
6. Mangoni AA, Close JC, Rodriguez S, Sherwood RA, Bryant CA, Swift CG, Jackson SH. Acute hypotensive effects of oral cisapride and erythromycin in healthy subjects. Br J Clin Pharmacol 2004; 58: 223-4.
7. Iwai T, Nakamura H, Takanashi H, Yogo K, Ozaki K, Ishizuka N, Asano T. Hypotensive mechanism of [Leu13]motilin in dogs in vivo and in vitro. Can J Physiol Pharmacol 1998; 76: 1103-9.
8. Tack J, Janssens J, Vantrappen G, Peeters T, Annese V, Depoortere I, Muls E, Bouillon R. Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis. Gastroenterology 1992; 103: 72-9.
9. McClave SA, Snider HL, Lowen CC, McLaughlin AJ, Greene LM, McCombs RJ, Rodgers L, Wright RA, Roy TM, Schumer MP. Use of residual volume as a marker for enteral feeding intolerance: prospective blinded comparison with physical examination and radiographic findings. J Parenter Enteral Nutr 1992; 16: 99-105.
10. Chapman MJ, Fraser RJ, Kluger MT, Buist MD, De Nichilo DJ. Erythromycin improves gastric emptying in critically ill patients intolerant of nasogastric feeding. Crit Care Med 2000; 28: 2334-7.
11. Berry MK, Russo A, Wishart JM, Tonkin A, Horowitz M, Jones KL. Effect of solid meal on gastric emptying of, and glycemic and cardiovascular responses to, liquid glucose in older subjects. Am J Physiol Gastrointest Liver Physiol 2003; 284: G655-G662.